Clinical trial
Bicalutamide in Treating Patients With AR-positive Metastatic Triple Negative Breast Cancer
NCT02353988 is registered in ClinicalTrials.gov with Jinling Hospital, China as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Bicalutamide in Treating Patients With AR-positive Metastatic Triple Negative Breast Cancer
- Lead sponsor
- Jinling Hospital, China
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- January 31, 2015
- Completion date
- May 31, 2017
- Enrollment
- 60 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.